Sera Prognostics, Inc.
Nasdaq SERA · Salt Lake City, UT
Works in Renal & urogenital · Women's health
Sera Prognostics, Inc. is a clinical trial sponsor based in Salt Lake City, UT, listed as Nasdaq SERA. It has 1 active clinical trial with 6,500 planned participants, in Renal & urogenital and Women's health. Since 2021 it has completed 1 trial and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq SERA
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Sera Prognostics, Inc
Sera Prognostics, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 6,500 planned participants, in Renal & urogenital, Women's health. Since 2021 it has completed 1 trial and stopped 0 early.
Sera Prognostics, Inc is based in Salt Lake City, UT and is listed as Nasdaq SERA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Sera Prognostics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2024-12-06.
Approve Suite is not affiliated with Sera Prognostics, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.